Steroid intraocular implants having an extended sustained release for a period of greater than two months

Details for Australian Patent Application No. 2011254090 (hide)

Owner Allergan, Inc.

Inventors Huang, Glenn T.; Nivaggioli, Thierry; Spada, Lon T.; Sugimoto, Hiroshi; Blanda, Wendy M.; Chang, James N.; Olejnik, Orest

Agent Davies Collison Cave

Pub. Number AU-A-2011254090

Parent 2010200935

Filing date 16 December 2011

Wipo publication date 19 January 2012

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/00 (2006.01)

A61K 31/573 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

Event Publications

19 January 2012 Application Open to Public Inspection

  Published as AU-A-2011254090

19 January 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011254091-Image forming apparatus, image forming method, and image forming program

2011254089-Road repair assembly and method of road repair